title: Review: in relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
authors.forename: Brian G
authors.initials: BG
authors.lastname: Weinshenker
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors